Original ArtcileJournal of Young PharmacistsVol. 17 | Issue 4 | 2025 | pp. 947–952Open access
Assessment of Health-Related Quality of Life in Chronic Kidney Disease Patients
- 1,
- 1,
- 1,
- 1*,
- 2
- 1 Department of Pharmacy Practice, Anurag Pharmacy College (Affiliated to Jawaharlal Nehru Technological University, Hyderabad), Ananthagiri, Kodad, Suryapeta, Telangana, INDIA.
- 2 Department of Pharmacognosy, Anurag Pharmacy College (Affiliated to Jawaharlal Nehru Technological University, Hyderabad), Ananthagiri, Kodad, Suryapeta, Telangana, INDIA.
Published in Journal of Young Pharmacists
Correspondence: Guntru Sangeetha Roy
Department of Pharmacy Practice, Anurag Pharmacy College (Affiliated to Jawaharlal Nehru Technological University, Hyderabad), Ananthagiri, Kodad, Suryapeta, Telangana, INDIA.
Email: sangeetharoyguntru@gmail.com
Copyright: © 2025 Manuscript Technomedia. This is an open access article.
- Published:
- Nov 8, 2025
- Received:
- May 12, 2025
- Accepted:
- Sep 30, 2025
- DOI:
- 10.5530/jyp.20250011
How to cite
Gayathri, P., Chowdhury, M. A., Rathod, U., Roy, G. S., & Chinnaeswaraiah, M. (2025). Assessment of Health-Related Quality of Life in Chronic Kidney Disease Patients. Journal of Young Pharmacists, 17(4), 947–952. https://doi.org/10.5530/jyp.20250011
Abstract
Background: Chronic Kidney Disease (CKD) is a long-term condition that affects patients’ physical, mental, and social well-being. As the disease progresses, symptoms and treatment demands can lower Health-Related Quality of Life (HRQOL). Assessing HRQOL helps evaluate disease impact and improve patient-centered care in CKD management. The purpose of the study is to evaluate how Chronic Kidney Disease affects the Health-Related Quality of Life (HRQOL) of patients. Materials and Methods: The goal was to gather demographic data, such as domicile, gender, and age. A face-to-face interview was conducted using the SF-36 Questionnaire to measure the HRQOL in CKD patients and establish a cross-sectional relationship between selected factors on HRQOL. Results: The results show how CKD steadily degrades quality of life while dialysis together with advanced disease severity makes patients experience worse physical difficulties and stronger emotional distress and reduced social activity. The health status becomes worse when patients have multiple health issues (HTN and DM) together with age characteristics and gender differences and being from a rural setting. The treatment of dialysis restricts patient mobility while it intensifies discomfort and leads to psychological distress. Conclusion: The improvement of life quality demands multiple essential interventions including patient-centered care along with holistic care and lifestyle changes and mental health support. The physical, psychological, and social effects of the illness as well as its therapies have an impact on it. The treatment of QoL demands an integrative approach including both life modification along with psychological aid and patient-oriented treatment methods and medical intervention strategies.
Keywords
Subject
Article metadata
| Title | Assessment of Health-Related Quality of Life in Chronic Kidney Disease Patients |
|---|---|
| Authors | Panga Gayathri; Mehdi Alom Chowdhury; Umesh Rathod; Guntru Sangeetha Roy; M. Chinnaeswaraiah |
| Affiliations | Department of Pharmacy Practice, Anurag Pharmacy College (Affiliated to Jawaharlal Nehru Technological University, Hyderabad), Ananthagiri, Kodad, Suryapeta, Telangana, INDIA.; Department of Pharmacognosy, Anurag Pharmacy College (Affiliated to Jawaharlal Nehru Technological University, Hyderabad), Ananthagiri, Kodad, Suryapeta, Telangana, INDIA. |
| Corresponding author | sangeetharoyguntru@gmail.com |
| Journal | Journal of Young Pharmacists |
| Volume / Issue | Vol. 17, Issue 4 (2025) |
Also in this issue
- Dual Nephroprotective Strategy of Dapagliflozin and Telmisartan in the Management of Diabetic Kidney Disease: A Comprehensive Reviewpp. 752–762
- Pharmacological Approaches in Alcohol Use Disorder-Exploring Off-Label an Emerging Treatments in Clinical and Preclinical Evidencepp. 763–769
- Artificial Intelligence in Hemovigilance: Advancing Blood Safety and Monitoring Systemspp. 770–776
- Advances in Green Analytical Techniques for Impurity Profiling in Pharmaceuticalspp. 777–783
- Pharma 4.0: Enhancing Process Robustness in Pharmaceutical Manufacturing through Industry 4.0 Integrationpp. 784–789
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026